InvestorsHub Logo
Followers 30
Posts 2777
Boards Moderated 3
Alias Born 10/24/2015

Re: NY1972 post# 153

Wednesday, 08/24/2022 6:58:40 PM

Wednesday, August 24, 2022 6:58:40 PM

Post# of 376
Another issue for them long-term is the fact they will add an anti-CD52 mAb, which causes profound lymphodepletion, or being able to overcome host rejection.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent FATE News